about
Antitumoral activity of snake venom proteins: new trends in cancer therapyThe crystal structure of a novel, inactive, lysine 49 PLA2 from Agkistrodon acutus venom: an ultrahigh resolution, AB initio structure determinationStructural Characterization of Myotoxic Ecarpholin S From Echis carinatus VenomCrystal structure of a dimeric Ser49- PLA₂-like myotoxic component of the Vipera ammodytes meridionalis venomics reveals determinants of myotoxicity and membrane damaging activityEffects of the Ga-As laser irradiation on myonecrosis caused by Bothrops Moojeni snake venom.Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum.Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins.Structural Basis for the Inhibition of a Phospholipase A2-Like Toxin by Caffeic and Aristolochic Acids.Therapeutic application of natural inhibitors against snake venom phospholipase A(2).Purification and preliminary crystallographic analysis of a new Lys49-PLA2 from B. Jararacussu.Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.Privileged frameworks from snake venom.Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A2.Alpha-type phospholipase A2 inhibitors from snake blood.Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.Computer-aided drug design of novel PLA2 inhibitor candidates for treatment of snakebite.Structural and functional evidence for membrane docking and disruption sites on phospholipase A2-like proteins revealed by complexation with the inhibitor suramin.A Lys49 phospholipase A2, isolated from Bothrops asper snake venom, induces lipid droplet formation in macrophages which depends on distinct signaling pathways and the C-terminal region.Crystallization and preliminary X-ray diffraction analysis of myotoxin I, a Lys49-phospholipase A2 from Bothrops moojeni.Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells.Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2.Nandrolone stimulates MyoD expression during muscle regeneration in the condition of myonecrosis induced by Bothrops jararacussu venom poisoning.Crystallization and preliminary X-ray diffraction analysis of a myotoxic Lys49-PLA2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide.Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom.Effect of suramin on myotoxicity of some crotalid snake venoms.Molecular characterization of an acidic phospholipase A(2) from Bothrops pirajai snake venom: synthetic C-terminal peptide identifies its antiplatelet region.Synthesis, characterization and bioactivity studies of novel 1,3,4-oxadiazole small molecule that targets basic phospholipase A2 from Vipera russelli.Purification and characterization of the first γ-phospholipase inhibitor (γPLI) from Bothrops jararaca snake serum.
P2860
Q27021928-F87B4C34-21CC-48BB-AC10-BB1066D5C3B7Q27641698-57F91F58-EEE5-40A3-B89C-2720D400CCE7Q27650993-F233F99D-AE97-4D36-8007-449F0226EEFFQ27677444-5CC27BAB-A201-465D-9AF3-9BA9B13CD2BFQ31032878-958C0B6B-A567-441E-B034-41F59A541BB4Q31120884-E9B798A3-DA82-47C2-9856-5E147AC14E74Q33205208-355CD350-0E30-45C5-BD83-F3339F48BC6FQ35699362-62F21B4B-B36A-4CDD-B78B-D1CC034B56EDQ35764977-F74909DD-A52F-4563-A93C-93419B064D85Q37083437-4FA93B0E-97CF-4821-A414-126452FA354DQ38292301-91221A30-2918-4D4E-AB7A-02462C3A594FQ38360688-119EA234-E01A-489B-A8F2-2F395C5A0990Q38959109-B7A5EE38-692A-4447-A208-FC3CE5FBDF93Q39201557-66F6BF81-7310-486B-B075-4D30B9033DE6Q39962923-AB7CCF29-47BB-43B7-9F09-AF88279D0B6FQ39974076-9F090EAF-DEAB-47FB-B6EF-83DFD4EB83E1Q40442267-7CFA37F0-3EA7-4721-8016-AAB20E526EAFQ41480789-875A773B-AAC7-4306-A050-28DC6DF30C8FQ41543218-107D1BB3-8FF6-4555-A981-B70D59CE03DBQ42018281-39561275-425C-4DFC-A3D1-0DAE28B76BC4Q42115492-E47C0823-F42F-484B-AB18-94D36A4DA4BFQ43011941-BF7968C2-C7C1-498C-B920-034D6E09C7C4Q43044253-D190A980-BD34-495C-8BB0-16574C44E77FQ43167411-BAF7873C-1081-4FA4-B2A5-3BCFCFD6ADE7Q44015437-14F89075-DBB5-457D-A82D-99CF3ABB59B9Q48059890-4CBEAB95-E8E6-4CEB-B13F-B58D71778EB1Q50221885-271EE83D-6B6C-4DAB-BD8A-3F811D7338B0Q52673983-FC35D26E-5738-4AD6-8911-55CA611FCA69
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lysine 49 phospholipase A2 proteins.
@ast
Lysine 49 phospholipase A2 proteins.
@en
Lysine 49 phospholipase A2 proteins.
@nl
type
label
Lysine 49 phospholipase A2 proteins.
@ast
Lysine 49 phospholipase A2 proteins.
@en
Lysine 49 phospholipase A2 proteins.
@nl
prefLabel
Lysine 49 phospholipase A2 proteins.
@ast
Lysine 49 phospholipase A2 proteins.
@en
Lysine 49 phospholipase A2 proteins.
@nl
P2093
P1433
P1476
Lysine 49 phospholipase A2 proteins.
@en
P2093
H S Selistre de Araujo
J E Fletcher
P304
P356
10.1016/S0041-0101(98)00188-3
P577
1999-03-01T00:00:00Z